New York, USA – Creative Biolabs is an expert in the field of antibody, especially focusing on antibody design and engineering. For years, with the joint effort of experienced technical staff and professors at Creative Biolabs, dozens of global customers have made great achievements in their projects regarding small molecules like antibody, which therefore push forward the step of precision medicine.
Since the first attempt of revealing the mystery of antibody and its essential significance in immunotherapy, large pharmaceutical companies adopt it as a crucial tool against many diseases that impair humans, such as cancer. Aiming to help customers in need of technical support and specific operations to discover antibody molecules with desired properties, Creative Biolabs has provided a series of services regarding antibody discovery that are supported with high-end technology platforms, including antibody engineering, antibody analysis, antibody labeling and human or humanized antibody services, etc.
The section of provisions about antibody analysis has always received popularity among global clients, in a systematic order covering de novo antibody sequencing, affinity measurement, epitope binning, immunogenicity assessment, isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), dual-polarization interferometry (DPI) and so on.
The first and foremost crucial step is antibody sequencing, of which the technology of Database Assisted Shotgun Sequencing (DASS) has received unprecedented success of 100% precise differentiation between the leucine and isoleucine, far surpassing other peers in the industry.
Those labs holding no affinity measurement techniques can relieve. Obtaining the sequencing info is the prerequisite, and analyzing the label-free interaction between biomolecules is another specialty of Creative Biolabs that involves managing the antibody affinity and kinetics with high-end optical phenomena based technologies like Biacore, ProteOn, etc.
Several high-throughput and analytical technology platforms are introduced for epitope binning to characterize monoclonal antibodies, including ForteBio Octet platform, ProteOn array system, Biacore system and IBIS MX96 & CFM, to deliver label free, real-time result of 99% accuracy. To assist customers and save their money as much as possible, crude samples are accepted.
“We are capable of helping you take a clearer look at antibodies,” from a scientist at Creative Biolabs who has been concentrated on the sector of antibody analysis. The ultimate goal of their team is simple and intuitive, i.e. improving precision medicine. For more relevant information, please visit https://www.creative-biolabs.com.
About Creative Biolabs
Creative Biolabs was founded in 2004 by a group of scientists who are dedicated to helping global medicine manufacturers and research institutes with their projects regarding Lifesciences, especially the antibody. The services scope is as comprehensive as that it covers producing mouse and rat monoclonal antibodies with hybridoma technology, generating human, monkey, rabbit, chicken, dog, llama and camel monoclonal antibodies adopting various antibody library technologies (including phage display, bacterial display and yeast display), conducting antibody humanization and affinity maturation using phage display and DNA mutagenesis approaches. Besides, OEM services for bulk scale antibody manufacturing are provided at the most competitive price in the industry.